Ford JM - Search Results

1

Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Nadauld LD, et al. Among authors: ford jm. Genome Biol. 2014 Aug 27;15(8):428. doi: 10.1186/s13059-014-0428-9. Genome Biol. 2014. PMID: 25315765 Free PMC article.

2

Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases.

Greer SU, Nadauld LD, Lau BT, Chen J, Wood-Bouwens C, Ford JM, Kuo CJ, Ji HP. Greer SU, et al. Among authors: ford jm. Genome Med. 2017 Jun 19;9(1):57. doi: 10.1186/s13073-017-0447-8. Genome Med. 2017. PMID: 28629429 Free PMC article.

3

Family history as a positive prognostic factor in gastric cancer.

Nadauld LD, Ford JM. Nadauld LD, et al. Among authors: ford jm. J Clin Oncol. 2012 Mar 1;30(7):683-4. doi: 10.1200/JCO.2011.40.1497. Epub 2012 Jan 23. J Clin Oncol. 2012. PMID: 22271484 No abstract available.

4

Molecular profiling of gastric cancer: toward personalized cancer medicine.

Nadauld LD, Ford JM. Nadauld LD, et al. Among authors: ford jm. J Clin Oncol. 2013 Mar 1;31(7):838-9. doi: 10.1200/JCO.2012.47.1714. Epub 2013 Jan 22. J Clin Oncol. 2013. PMID: 23341521 No abstract available.

5

Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin Embedded Tumors with Droplet Digital PCR.

Nadauld L, Regan JF, Miotke L, Pai RK, Longacre TA, Kwok SS, Saxonov S, Ford JM, Ji HP. Nadauld L, et al. Among authors: ford jm. Transl Med (Sunnyvale). 2012;2(2):1000107. doi: 10.4172/2161-1025.1000107. Transl Med (Sunnyvale). 2012. PMID: 23682346 Free PMC article.

6

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer.

Xia LC, Van Hummelen P, Kubit M, Lee H, Bell JM, Grimes SM, Wood-Bouwens C, Greer SU, Barker T, Haslem DS, Ford JM, Fulde G, Ji HP, Nadauld LD. Xia LC, et al. Among authors: ford jm. Sci Rep. 2020 Mar 19;10(1):5009. doi: 10.1038/s41598-020-61643-6. Sci Rep. 2020. PMID: 32193467 Free PMC article.

7

Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2-Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine.

Haslem DS, Ji HP, Ford JM, Nadauld LD. Haslem DS, et al. Among authors: ford jm. JCO Precis Oncol. 2017 Jun 27;1:PO.16.00055. doi: 10.1200/PO.16.00055. eCollection 2017. JCO Precis Oncol. 2017. PMID: 32913966 Free PMC article. No abstract available.

8

Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.

Nadauld LD, Ford JM, Pritchard D, Brown T. Nadauld LD, et al. Among authors: ford jm. Health Aff (Millwood). 2018 May;37(5):751-756. doi: 10.1377/hlthaff.2017.1575. Health Aff (Millwood). 2018. PMID: 29733728 Review.

9

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Mills AM, et al. Among authors: ford jm. Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321. Am J Surg Pathol. 2014. PMID: 25229768 Free PMC article.

10

Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.

Schiffman JD, Wang Y, McPherson LA, Welch K, Zhang N, Davis R, Lacayo NJ, Dahl GV, Faham M, Ford JM, Ji HP. Schiffman JD, et al. Among authors: ford jm. Cancer Genet Cytogenet. 2009 Aug;193(1):9-18. doi: 10.1016/j.cancergencyto.2009.03.005. Cancer Genet Cytogenet. 2009. PMID: 19602459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters